Critical Appraisal of Four IL-6 Immunoassays
Open Access
- 9 February 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (2), e30659
- https://doi.org/10.1371/journal.pone.0030659
Abstract
Interleukin-6 (IL-6) contributes to numerous inflammatory, metabolic, and physiologic pathways of disease. We evaluated four IL-6 immunoassays in order to identify a reliable assay for studies of metabolic and physical function. Serial plasma samples from intravenous glucose tolerance tests (IVGTTs), with expected rises in IL-6 concentrations, were used to test the face validity of the various assays. IVGTTs, administered to 14 subjects, were performed with a single infusion of glucose (0.3 g/kg body mass) at time zero, a single infusion of insulin (0.025 U/kg body mass) at 20 minutes, and frequent blood collection from time zero to 180 minutes for subsequent Il-6 measurement. The performance metrics of four IL-6 detection methods were compared: Meso Scale Discovery immunoassay (MSD), an Invitrogen Luminex bead-based multiplex panel (LX), an Invitrogen Ultrasensitive Luminex bead-based singleplex assay (ULX), and R&D High Sensitivity ELISA (R&D). IL-6 concentrations measured with MSD, R&D and ULX correlated with each other (Pearson Correlation Coefficients r = 0.47–0.94, p<0.0001) but only ULX correlated (r = 0.31, p = 0.0027) with Invitrogen Luminex. MSD, R&D, and ULX, but not LX, detected increases in IL-6 in response to glucose. All plasma samples were measurable by MSD, while 35%, 1%, and 4.3% of samples were out of range when measured by LX, ULX, and R&D, respectively. Based on representative data from the MSD assay, baseline plasma IL-6 (0.90±0.48 pg/mL) increased significantly as expected by 90 minutes (1.29±0.59 pg/mL, p = 0.049), and continued rising through 3 hours (4.25±3.67 pg/mL, p = 0.0048). This study established the face validity of IL-6 measurement by MSD, R&D, and ULX but not LX, and the superiority of MSD with respect to dynamic range. Plasma IL-6 concentrations increase in response to glucose and insulin, consistent with both an early glucose-dependent response (detectable at 1–2 hours) and a late insulin-dependent response (detectable after 2 hours).Keywords
This publication has 16 references indexed in Scilit:
- IL-6 selectively stimulates fat metabolism in human skeletal muscleAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- Release of Inflammatory Mediators by Human Adipose Tissue Is Enhanced in Obesity and Primarily by the Nonfat Cells: A ReviewMediators of Inflammation, 2010
- Adipose tissue as an endocrine organMolecular and Cellular Endocrinology, 2009
- Relationships Between Circulating Metabolic Intermediates and Insulin Action in Overweight to Obese, Inactive Men and WomenDiabetes Care, 2009
- Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6Physiological Reviews, 2008
- Interleukin-6 Directly Increases Glucose Metabolism in Resting Human Skeletal MuscleDiabetes, 2007
- Insulin stimulates interleukin-6 and tumor necrosis factor-α gene expression in human subcutaneous adipose tissueAmerican Journal of Physiology-Endocrinology and Metabolism, 2004
- Effect of the volume and intensity of exercise training on insulin sensitivityJournal of Applied Physiology, 2004
- Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in HumansCirculation, 2002
- Increase of plasma IL-6 concentration with age in healthy subjectsLife Sciences, 1992